Dr. Gregory J. Challener, MD
Rheumatology (Rheumatology Physician)
- Medicare participating
At a glance
- Years since graduation
- 7
- In the NPI registry since
- 2019
- Medicare patients seen, 2024
- 45
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2019Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Rheumatology Physician primary
MA license 292803
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Brigham and Women's Hospital Boston, MA
- Massachusetts General Hospital Boston, MA
- Newton-Wellesley Hospital Newton, MA
- North Shore Medical Center - Salem, MA
- Wentworth-Douglass Hospital Dover, NH
Medical groups
- Massachusetts General Physicians Organization Inc (3,558 clinicians)
- The General Hospital Corporation (1,267 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 45
- Services billed
- 102
- Patients’ average age
- 74
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Prednisone Other prescribers in Boston, MA | 95 |
| Methotrexate (methotrexate sodium) Other prescribers in Boston, MA | 50 |
| Actemra Actpen (tocilizumab) | 32 |
| Gabapentin Other prescribers in Boston, MA | 21 |
| Humira(Cf) Pen (adalimumab) Other prescribers in Boston, MA | 17 |
| Hydroxychloroquine Sulfate Other prescribers in Boston, MA | 17 |
| Allopurinol Other prescribers in Boston, MA | 17 |
| Colchicine Other prescribers in Boston, MA | 16 |
| Actemra (tocilizumab) | 13 |
| Leflunomide Other prescribers in Boston, MA | 12 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 1 companies reported 1 payments worth $99.99 in total to this clinician.
| Janssen Biotech, Inc. | $99.99 |
|---|
| Education | $99.99 |
|---|
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Janssen Biotech, Inc. Mar 28, 2025 | Education TREMFYA · Immunology · in-kind | $99.99 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.